Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis

Gynecologic Oncology

Volumn 112, Issue 2, 2009, Pages 337-341

  Landrum, Lisa M ^a   Moore, Kathleen N ^a   Myers, Tashanna K N ^a   Lanneau Jr , Grainger S ^a   McMeekin, D Scott ^a   Walker, Joan L ^a   Gold, Michael A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Chemotherapy; Cytoreduction; Optimal debulking; Radiation

Indexed keywords

PLATINUM;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149513086     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.10.009     Document Type: Article

References (16)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 2 (2008) 71-96
2. Thigpen J.T., Brady M.F., Alvarez R.D., Adelson M.D., Homesley H.D., Manetta A., et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J. Clin. Oncol. 17 6 (1999) 1736-1744
3. Lentz S.S., Brady M.F., Major F.J., Reid G.C., and Soper J.T. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 14 2 (1996) 357-361
4. Whitney C.W., Brunetto V.L., Zaino R.J., Lentz S.S., Sorosky J., Armstrong D.K., et al. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92 1 (2004) 4-9
5. Pliskow S., Penalver M., and Averette H.E. Stage III and Stage IV endometrial carcinoma: a review of 41 cases. Gynecol. Oncol. 38 2 (1990) 210-215
6. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 92 3 (2004) 744-751
7. Sutton G., Axelrod J.H., Bundy B.N., Roy T., Homesley H.D., Malfetano J.H., et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with Stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol. Oncol. 97 3 (2005) 755-763
8. Randall M.E., Filiaci V.L., Muss H., Spirtos N.M., Mannel R.S., Fowler J., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol 24 1 (2006) 36-44
9. Fleming G.F., Brunetto V.L., Cella D., Look K.Y., Reid G.C., Munkarah A.R., et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 22 11 (2004) 2159-2166
10. Goff B.A., Goodman A., Muntz H.G., Fuller Jr. A.F., Nikrui N., and Rice L.W. Surgical Stage IV endometrial carcinoma: a study of 47 cases. Gynecol. Oncol. 52 2 (1994) 237-240
11. Chi D.S., Welshinger M., Venkatraman E.S., and Barakat R.R. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol. Oncol. 67 1 (1997) 56-60
12. Bristow R.E., Zerbe M.J., Rosenshein N.B., Grumbine F.C., and Montz F.J. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol. Oncol. 78 2 (2000) 85-91
13. Ayhan A., Taskiran C., Celik C., Yuce K., and Kucukali T. The influence of cytoreductive surgery on survival and morbidity in Stage IVB endometrial cancer. Int. J. Gynecol. Cancer 12 5 (2002) 448-453
14. Lambrou N.C., Gomez-Marin O., Mirhashemi R., Beach H., Salom E., meida-Parra Z., et al. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol. Oncol. 93 3 (2004) 653-658
15. Griffiths C.T., Grogan R.H., and Hall T.C. Advanced ovarian cancer: primary treatment with surgery, radiotherapy, and chemotherapy. Cancer 29 1 (1972) 1-7
16. Greer B.E., and Hamberger A.D. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation. Gynecol. Oncol. 16 3 (1983) 365-373